(Q37721612)

22 August 2017

1 reference

title

The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis (English)

1 reference

antiphospholipid syndrome

22 August 2017

0 references

1 reference

J H Rand

1

1 reference

22 August 2017

X-X Wu

series ordinal

2

1 reference

22 August 2017

A S Quinn

series ordinal

3

1 reference

22 August 2017

D J Taatjes

series ordinal

4

1 reference

22 August 2017

language of work or name

1 reference

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

19

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

460-469

1 reference

Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Annexins: from structure to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Annexins: multifunctional components of growth and adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phosph

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Human placental anticoagulant protein: isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Three-dimensional structure of membrane-bound annexin V. A correlative electron microscopy-X-ray crystallography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Growth of Protein 2-D Crystals on Supported Planar Lipid Bilayers Imaged in Situ by AFM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Protein-membrane interactions: blood clotting on nanoscale bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Identification and localization of slow, natural, cooperative unfolding in the hematopoietic cell kinase SH3 domain by amide hydrogen exchange and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Annexin A5 multitasking: a potentially novel antiatherothrombotic agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Anti-annexin A5 antibodies in reproductive failures in relation to antiphospholipid antibodies and phosphatidylserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Anti-annexin V antibodies: are they prothrombotic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Antibodies against annexin A5: detection pitfalls and clinical associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Antiphospholipid antibody syndrome: rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Efficacy of antimalarials in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

Protein terminology tangle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310361485

21 January 2018

Identifiers

DOI

10.1177/0961203310361485

1 reference

22 August 2017

1 reference